These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24930593)

  • 21. Mycobacterium tuberculosis-specific CD8+ T cell recall in convalescing TB subjects with HIV co-infection.
    Ongaya A; Huante MB; Mwangi P; Keiser PH; Amukoye E; Endsley JJ
    Tuberculosis (Edinb); 2013 Dec; 93 Suppl():S60-5. PubMed ID: 24388651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution.
    Michel P; Balde AT; Roussilhon C; Aribot G; Sarthou JL; Gougeon ML
    J Infect Dis; 2000 Jan; 181(1):64-75. PubMed ID: 10608752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines and HIV/AIDS: a critical look at the existing relationship between them.
    Ekene OC
    Roum Arch Microbiol Immunol; 2008; 67(3-4):67-80. PubMed ID: 19496474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HIV adaptive immunity: determinants for viral persistence.
    Yamamoto H; Matano T
    Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells and HIV infection; immunity with viral transmission versus compromised cellular immunity?
    Knight SC
    Immunobiology; 2001 Dec; 204(5):614-21. PubMed ID: 11846226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1.
    Bui JK; Mellors JW
    AIDS; 2015 Sep; 29(15):1911-5. PubMed ID: 26355569
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell exhaustion in HIV-1 infection: role of suppressor cells.
    Seddiki N; Brezar V; Draenert R
    Curr Opin HIV AIDS; 2014 Sep; 9(5):452-8. PubMed ID: 25010895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient T cell receptor beta-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotyping.
    Soudeyns H; Champagne P; Holloway CL; Silvestri GU; Ringuette N; Samson J; Lapointe N; Sékaly RP
    J Infect Dis; 2000 Jan; 181(1):107-20. PubMed ID: 10608757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human immunodeficiency virus type-1 through autophagy.
    Campbell GR; Spector SA
    Curr Opin Microbiol; 2013 Jun; 16(3):349-54. PubMed ID: 23747172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current topics in HIV-1 pathogenesis: The emergence of deregulated immuno-metabolism in HIV-infected subjects.
    Dagenais-Lussier X; Mouna A; Routy JP; Tremblay C; Sekaly RP; El-Far M; Grevenynghe Jv
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):603-13. PubMed ID: 26409789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities.
    Lu L; Yu F; DU LY; Xu W; Jiang SB
    Chin Med J (Engl); 2013 Jun; 126(12):2374-9. PubMed ID: 23786957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate immunity in HIV-1 infection: epithelial and non-specific host factors of mucosal immunity- a workshop report.
    Nittayananta W; Weinberg A; Malamud D; Moyes D; Webster-Cyriaque J; Ghosh S
    Oral Dis; 2016 Apr; 22 Suppl 1():171-80. PubMed ID: 27109285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sooner the better: innate immunity as a path toward the HIV cure.
    Tomalka J; Ghneim K; Bhattacharyya S; Aid M; Barouch DH; Sekaly RP; Ribeiro SP
    Curr Opin Virol; 2016 Aug; 19():85-91. PubMed ID: 27497036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered antigen-presenting cells during HIV-1 infection.
    Piguet V; Caucheteux SM; Iannetta M; Hosmalin A
    Curr Opin HIV AIDS; 2014 Sep; 9(5):478-84. PubMed ID: 25093528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure.
    Vigano S; Bobisse S; Coukos G; Perreau M; Harari A
    Front Immunol; 2020; 11():1350. PubMed ID: 32714330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interleukin-21: a key cytokine for controlling HIV and other chronic viral infections].
    Iannello A; Allam O; Samarani S; Ahmad A
    Med Sci (Paris); 2012; 28(6-7):605-11. PubMed ID: 22805136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hiding in plain sight: how HIV evades innate immune responses.
    Manel N; Littman DR
    Cell; 2011 Oct; 147(2):271-4. PubMed ID: 22000008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between HIV-1 and the cell-autonomous innate immune system.
    Towers GJ; Noursadeghi M
    Cell Host Microbe; 2014 Jul; 16(1):10-8. PubMed ID: 25011104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS.
    Maelfait J; Seiradake E; Rehwinkel J
    Bioessays; 2014 Jul; 36(7):649-57. PubMed ID: 24782340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive Immune Responses during Salmonella Infection.
    Cummings LA; Deatherage BL; Cookson BT
    EcoSal Plus; 2009 Aug; 3(2):. PubMed ID: 26443770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.